Wall Street analysts expect that Equifax Inc. (NYSE:EFX) will report $858.07 million in sales for the current quarter, Zacks Investment Research reports. Six analysts have made estimates for Equifax’s earnings. The lowest sales estimate is $855.38 million and the highest is $860.98 million. Equifax posted sales of $834.80 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 2.8%. The firm is scheduled to announce its next quarterly earnings results on Thursday, November 8th.

According to Zacks, analysts expect that Equifax will report full year sales of $3.47 billion for the current year, with estimates ranging from $3.46 billion to $3.47 billion. For the next fiscal year, analysts expect that the company will report sales of $3.66 billion per share, with estimates ranging from $3.63 billion to $3.70 billion. Zacks’ sales averages are a mean average based on a survey of sell-side research firms that that provide coverage for Equifax.

Equifax (NYSE:EFX) last released its quarterly earnings data on Wednesday, July 25th. The credit services provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.02. The company had revenue of $876.90 million during the quarter, compared to analysts’ expectations of $886.00 million. Equifax had a net margin of 14.76% and a return on equity of 22.03%. The firm’s quarterly revenue was up 2.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.60 EPS.

Several equities research analysts have recently commented on EFX shares. JPMorgan Chase & Co. boosted their price target on shares of Equifax from $135.00 to $150.00 and gave the company an “overweight” rating in a report on Friday, July 27th. Morgan Stanley reduced their price target on shares of Equifax from $120.00 to $117.00 and set an “equal weight” rating for the company in a report on Thursday, July 26th. Zacks Investment Research upgraded shares of Equifax from a “sell” rating to a “hold” rating in a report on Friday, July 20th. Finally, ValuEngine upgraded shares of Equifax from a “hold” rating to a “buy” rating in a report on Tuesday, September 11th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and eight have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $124.31.

Equifax stock traded down $3.75 during trading hours on Friday, hitting $134.31. The company had a trading volume of 25,266 shares, compared to its average volume of 1,008,646. The stock has a market cap of $16.46 billion, a price-to-earnings ratio of 23.11, a price-to-earnings-growth ratio of 3.11 and a beta of 0.86. The company has a debt-to-equity ratio of 0.80, a current ratio of 1.40 and a quick ratio of 1.40. Equifax has a 1 year low of $91.88 and a 1 year high of $138.69.

The firm also recently declared a quarterly dividend, which was paid on Friday, September 14th. Stockholders of record on Friday, August 24th were issued a $0.39 dividend. The ex-dividend date was Thursday, August 23rd. This represents a $1.56 annualized dividend and a dividend yield of 1.16%. Equifax’s dividend payout ratio is currently 26.13%.

Several large investors have recently bought and sold shares of the company. Qube Research & Technologies Ltd raised its stake in shares of Equifax by 1,375.6% during the 2nd quarter. Qube Research & Technologies Ltd now owns 1,151 shares of the credit services provider’s stock worth $144,000 after acquiring an additional 1,073 shares in the last quarter. Valeo Financial Advisors LLC bought a new position in shares of Equifax during the 2nd quarter worth approximately $158,000. Piedmont Investment Advisors LLC bought a new position in shares of Equifax during the 2nd quarter worth approximately $175,000. Point72 Asia Hong Kong Ltd raised its stake in shares of Equifax by 1,186.4% during the 1st quarter. Point72 Asia Hong Kong Ltd now owns 1,518 shares of the credit services provider’s stock worth $179,000 after acquiring an additional 1,400 shares in the last quarter. Finally, Deroy & Devereaux Private Investment Counsel Inc. bought a new position in shares of Equifax during the 2nd quarter worth approximately $200,000. Institutional investors and hedge funds own 92.56% of the company’s stock.

About Equifax

Equifax Inc provides information solutions and human resources business process outsourcing services for businesses, governments, and consumers. The company operates through four segments: U.S. Information Solutions (USIS), International, Workforce Solutions, and Global Consumer Solutions. The USIS segment offers consumer and commercial information services, such as credit information and credit scoring, credit modeling and portfolio analytics, locate, fraud detection and prevention, identity verification, and other consulting; mortgage loan origination information; financial marketing; and identity management services.

Featured Article: Leveraged Buyout (LBO)

Get a free copy of the Zacks research report on Equifax (EFX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Equifax (NYSE:EFX)

Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.